These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34 related articles for article (PubMed ID: 12693296)
1. [Ethical problems in randomized clinical trials from the aspect of statistics. Part I. Is patient randomization acceptable from the ethical viewpoint?]. Haas T Cas Lek Cesk; 2001 Jun; 140(11):335-42. PubMed ID: 11431853 [TBL] [Abstract][Full Text] [Related]
3. Power and sample size simulations for Randomized Play-the-Winner rules. Guimaraes P; Palesch Y Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219 [TBL] [Abstract][Full Text] [Related]
4. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking. Viera AJ; Bangdiwala SI Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956 [TBL] [Abstract][Full Text] [Related]
5. [Ethical problems in randomized clinical studies from the aspect of statistics. Part II: when should patient randomization be stopped of modified?]. Haas T Cas Lek Cesk; 2003 Jan; 142(1):34-8. PubMed ID: 12693296 [TBL] [Abstract][Full Text] [Related]
6. Randomized phase II designs in cancer clinical trials: current status and future directions. Lee JJ; Feng L J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154 [TBL] [Abstract][Full Text] [Related]
8. Clinical trial design issues: at least 10 things you should look for in clinical trials. Glasser SP; Howard G J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199 [TBL] [Abstract][Full Text] [Related]
9. A course for clinical trial personnel in clinical study designs, randomization, allocation schedules, and interactive response systems. Golm GT; Bradstreet TE; Coffey LA Pharm Stat; 2011; 10(2):175-82. PubMed ID: 20967893 [TBL] [Abstract][Full Text] [Related]